Title | WHY COMPROMISE |
Brand | GILEAD |
Product / Service | BIKTARVY |
Category | A03. Illustration |
Entrant | WARD6 Sydney, AUSTRALIA |
Idea Creation | WARD6 Sydney, AUSTRALIA |
Name | Company | Position |
---|---|---|
Grant Foster | Ward 6 Australia | Creative Director |
Richard Price | Ward 6 Australia | Senior Art Director |
Steve Samuel | Ward6 Australia | Senior Copywriter |
Alisa Knapman | Ward 6 Australia | Medical Writer |
Scott Davis | Ward 6 Australia | Strategy Director |
Daniela Rocca | Ward 6 Australia | Group Account Director |
Watermark Pty Ltd | Watermark Pty Ltd | Illustrator |
Mark Manuele | Gilead Sciences | Business Unit Director, HIV |
George Saad | Gilead Sciences | Product Manager |
For years, compromise was the acceptable norm in HIV treatment. It meant patients were being prescribed treatments less than ideal. While all worked incredibly well to suppress the virus, which is the ultimate treatment goal, most older treatments came with side effects. Enter Biktarvy, efficacious, safe and tolerable, but most importantly, fewer compromises. Patients living with HIV no longer needed to compromise renal function, cardiovascular health or bone density, just to name a few. The Why Compromise Booklet is an inspiring expression of living uncompromised, that delivers product information for doctors and patients in an entirely original and empowering way. With over 16,000 copies made, it has helped reinforce one of the many benefits of this new HIV treatment.